Initial preclinical efforts demonstrated that only MCL-1, but not BCL-2 or BCL-xL targeting anti-sense oligonucleotides are capable to impair MM cell survival [84, 85]. The gene discussed is MCL1; the disease is Miyoshi myopathy.